Aposense

Aposense is an innovative biotechnology company focused on developing transformational delivery technologies for macromolecules. Aposense's pioneering technology, known as Molecular Nano-Motors (MNMs), utilizes a novel mechanism leveraging membrane electrical forces to facilitate the entry of charged molecules into cells. This groundbreaking approach opens new treatment avenues for a wide range of diseases by enabling the delivery of molecules that are traditionally difficult to administer, such as oligonucleotide-based drugs (siRNA, ASO). Aposense is located at 5-7 Odem St., Petah Tikva, IL.

Equipped with state-of-the-art research facilities, Aposense collaborates with leading research organizations to advance its innovative solutions. The company's team of experienced scientists has demonstrated the therapeutic potential of the MNM technology through numerous preclinical studies, with a Phase I study planned for later this year. Aposense is dedicated to pushing the boundaries of biotechnology to create impactful solutions for global health challenges.

Aposense is committed to innovation and scientific excellence, which has garnered recognition from key opinion leaders in the pharmaceutical industry and non-governmental organizations such as the Bill & Melinda Gates Foundation. We invite the manager of Aposense to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.